Navigation Links
Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study
Date:6/16/2009

ROCKVILLE, Md., June 16 /PRNewswire-USNewswire/ -- According to a new report by HHS' Agency for Healthcare Research and Quality, there is insufficient evidence to conclude that genetic testing for two gene mutations in adults with a history of blood clots helps to prevent a condition known as deep-vein thrombosis or to improve other clinical outcomes.

The report, a summary of which will be published in the June 17 issue of JAMA, also failed to find any benefit from genetic testing of family members of patients who have at least one of the two mutations -- known as Factor V Leiden (FVL) and prothrombin G20210A -- as well as a history of deep-vein thrombosis.

As many as 600,000 Americans each year may have deep-vein thrombosis -- blood clots that form in the legs or pelvis. The condition occurs most commonly in people who are sedentary for a long period of time, such as when recovering from surgery or traveling long distances. The true number of people who develop a pulmonary embolism is unknown, but AHRQ data for hospital patients show that 258,000 individuals were diagnosed with the condition in 2006, and 20,000 died as a result.

"While genetic testing shows great promise to improve treatment and prevent disease, this report clearly shows that we need more research and evidence to achieve its full potential," said AHRQ Director Carolyn M. Clancy, M.D. "But people can help reduce their likelihood of developing a blood clot by talking with their doctor about precautions."

The evidence report was requested and supported by the Office of Public Health Genomics (OPHG) at HHS' Centers for Disease Control and Prevention. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, established by OPHG in 2005, will use this evidence report and other evidence to make recommendations on the validity and utility of genetic tests for FVL and prothrombin G20
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatient Services
2. Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed
3. Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
4. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
5. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
6. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
7. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
8. Industry Executives Finding Value in Shift of Scientific Publications
9. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
10. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
11. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...-NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecompan...surgicaltreatmentsforthespine,announcedtodaythatit...5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocuson...sproductsandwillincludecommentsfrommanagementfollo...ersare1-877-407-4018fordomesticcallersand1-201-689...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/25/2009)...-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/II...iveRandomizedOralTherapyEvaluationinCrohn,sdisease...erate-to-severeCrohn,sdiseasedemonstratedclinicale...Thestudydemonstratedevidenceofclinicalefficacyinth...reaseintheCrohn,sDiseaseActivityIndex(CDAI)inpatie...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 1Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 2Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 3Access Pharmaceuticals Provides Update on ProLindac 28TM 29 Phase 2 Ovarian Cancer Trial and Clinical Development Plan 47461 4BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 1National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 2National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 3
...7 Trius Therapeutics, Inc. announced,today that i...-701, an,antibacterial drug candidate intended for...bacterial infections, including those caused by MR...ght subject single and,multiple ascending dose tri...tics of the oral dosage form of the drug and will ...
...uided Nanoparticles May Deliver Treatments to Huma... used,magnetic fields and tiny iron-bearing partic...ood vessels. The research, done in animals, may le...o repair injured or diseased,organs in people., (...07/DC10966 ), The study team, led by Robert J. L...
Other Medicine Technology:Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701 2Researchers Use Magnetism to Target Cells to Animal Arteries 2Researchers Use Magnetism to Target Cells to Animal Arteries 3Researchers Use Magnetism to Target Cells to Animal Arteries 4
(Date:11/25/2009)...wswire/-SentinelleMedicalInc.,aleadingmanufacturer...CalgaryScientificInc.,aleadingproviderofsoftwareen...s(TM)Breast4DAdvancedVisualizationsoftware. ,, ...ntWebclientbasedmedicalimagingofferinginthemarket....o-footprintaccess-requiringnosoftwaredownload,andr...
(Date:11/25/2009)...swire-USNewswire/--AnarticlebyJanetWoodcock,M.D.,d...h,titled"ADifficultBalance-PainManagement,DrugSafe...EnglandJournalofMedicine. ,, (Logo: http://www....Inthearticle,WoodcockdiscussesFDAeffortstostrikeab...itandmanagingtherisksposedbyvariousanalgesics.Asex...
(Date:11/25/2009)...usiness,andPressJoinEfforttoEducate ,, MEMPHIS...eNationalBipolarFoundationandtheMedicAlertFoundati...e"program,whichisnowbeingwidelyacceptedasapreventi...ionalBipolarFoundationreceivedaproclamationofendor...norofLouisianaMitchLandrieu.TheNationalBipolarFoun...
(Date:11/25/2009)...out of a collaboration between UCLA engineers and ...rly 10 million Americans who suffer from periphera...g of the arteries, peripheral arterial disease, or...rowed arteries reduce blood flow to the limbs. The...isease, heart attack and stroke, and its progressi...
(Date:11/25/2009)...matoid arthritis, could help newly diagnosed diabe... (HealthDay News) -- A drug commonly used to treat...ow also shows some promise in helping patients new...rituximab (Rituxan), helped patients keep producin...se had destroyed some of their pancreatic beta cel...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...ormation is Meaningful,and in Appropriate Context,...logy Association (AdvaMed) today expressed support...ionships with physicians by,putting forth key chan...ed innovation in medical technology relies on dire...
...inating against a variety of infectious diseases ...ther than needles has proved able to produce a st...wo new studies. , The results build on previous s...ines developed at the Michigan Nanotechnology Inst...
...in Florida and Texas, JACKSONVILLE, Fla. and BETH...TM) today announced an agreement to equip physicia...ing service under,Availity,s private label, CarePr...g of Blue Cross and Blue Shield of,Florida, Humana...
...6-month study , , TUESDAY, Feb. 26 (Healt...ins the antiretroviral drug tenofovir is safe for ...a six-month study of 200 women in India and the Un...le to adhere to a regimen of either daily or sex-d...
...nd Fund Health Needs, WASHINGTON, Feb. 26 A coal...a newspaper and radio advertising,campaign in supp...ky,s,cigarette tax by 70 cents per pack, reduce sm... Kentucky lawmakers to support House Bill,443, spo...
...s, Inc. (Nasdaq: ADLS ), a biopharmaceutical comp...ercialization of novel drugs in the,therapeutic ar... today,announced that it will present at Susquehan...cgi-bin/prnh/20080218/ALSLOGO ), Advanced Life Sc...
Other Medicine News:Health News:AdvaMed Supports Key Changes to Disclosure Legislation 2Health News:AdvaMed Supports Key Changes to Disclosure Legislation 3Health News:Nanoemulsion vaccines show increasing promise 2Health News:Nanoemulsion vaccines show increasing promise 3Health News:Nanoemulsion vaccines show increasing promise 4Health News:Availity Engages Prematics to Deploy Electronic Prescribing 2Health News:Availity Engages Prematics to Deploy Electronic Prescribing 3Health News:HIV Drug in Microbicide Gel Safe for Daily Use 2Health News:Health Groups Launch Ad Campaign Supporting 70-Cent Increase in Kentucky Cigarette Tax 2Health News:Advanced Life Sciences to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference 2
...y that a second mirror adds, then you may want to ...same 1.5x magnification as the G-1 but offers two ... Available in standard (flange) or new glass NF (n...anged" model for laser use. Provides broader vie...
Direct Image AFX SSV®
Direct Image High-Mag SSV®
Direct Image Mid Field
Medicine Products: